Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation

Research group: Nanobiotechnology Año: 2009
Tipo de publicación: Artículo
Autores: Francesc X. Guix; Gerard Ill-Raga; Ramona Bravo; Tadashi Nakaya; Gianni de Fabritiis; Mireia Coma; Gian Pietro Miscione; Jordi Villà-Freixa; Toshiharu Suzuki; Xavier Fernández-Busquets; Miguel A. Valverde; Bart de Strooper; Francisco J. Muñoz
Journal: Brain Volumen: 132
Número: 5 Páginas: 1335-1345
Abstract:
Alzheimer's disease neuropathology is characterized by neuronal death, amyloid β-peptide deposits and neurofibrillary tangles composed of paired helical filaments of tau protein. Although crucial for our understanding of the pathogenesis of Alzheimer's disease, the molecular mechanisms linking amyloid β-peptide and paired helical filaments remain unknown. Here, we show that amyloid β-peptide-induced nitro-oxidative damage promotes the nitrotyrosination of the glycolytic enzyme triosephosphate isomerase in human neuroblastoma cells. Consequently, nitro-triosephosphate isomerase was found to be present in brain slides from double transgenic mice overexpressing human amyloid precursor protein and presenilin 1, and in Alzheimer's disease patients. Higher levels of nitro-triosephosphate isomerase (P Alzheimer's disease cortex and hippocampus from double transgenic mice overexpressing amyloid precursor protein and presenilin 1. Furthermore, nitro-triosephosphate isomerase formed large β-sheet aggregates in vitro and in vivo, as demonstrated by turbidometric analysis and electron microscopy. Transmission electron microscopy (TEM) and atomic force microscopy studies have demonstrated that nitro-triosephosphate isomerase binds tau monomers and induces tau aggregation to form paired helical filaments, the characteristic intracellular hallmark of Alzheimer's disease brains. Our results link oxidative stress, the main etiopathogenic mechanism in sporadic Alzheimer's disease, via the production of peroxynitrite and nitrotyrosination of triosephosphate isomerase, to amyloid β-peptide-induced toxicity and tau pathology.
[ Volver ]